• Home
  • About Us
  • Pipeline
  • Investors
  • Media Center
    • News Releases
    • Publications
  • Events
  • Careers
  • Contact Us
  • Site Map
  • Home
  • About Us
  • Pipeline
  • Investors
  • Media Center
    • News Releases
    • Publications
  • Events
  • Careers
  • Media Center
  • News Releases
  • Publications

Press Releases

Title Published Date
Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of Tele-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer Dec 03, 2019
Lexicon Pharmaceuticals Receives Formal Dispute Resolution Request Decision from FDA’s Office of New Drugs for Sotagliflozin in Type 1 Diabetes Dec 02, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Nov 26, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Nov 14, 2019
Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update Nov 07, 2019
Lexicon Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call and Webcast on November 7, 2019 Nov 01, 2019
Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical Symposium Oct 02, 2019
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement with Sanofi Sep 10, 2019
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual Meeting Sep 10, 2019
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Aug 30, 2019
  • 3
  • ...
  • 5
  • 6
  • 7
  • 8
  • 9
  • ...
  • 11
  • 12

Precision Science   »   Pioneering Medicine   »   Patient Driven

Lexicon Pharmaceuticals logo
Thank you for your interest. Your e-mail will be added to our list for news alerts.
Sorry, our system is unable to handle this right now. Please contact us directly.
  • Home
  • About Us
  • Pipeline
  • Investors
  • Media Center
    • News Releases
    • Publications
  • Events
  • Careers
Copyright © 2022, Lexicon Pharmaceuticals, Inc. All Rights Reserved
  • Privacy Policy
  • Accessibility
  • Terms of Use
  • Vendor Terms
  • Contact Us
  • Sitemap
end of page